Clinical Trials List
Protocol NumberNS863A-P2-01
Not yet recruiting
2026-07-01 - 2029-12-31
Phase II
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 侯鈞賀 Division of Ophthalmology
- 郭耀文 Division of Thoracic Medicine
- YEN-HUNG LIN Division of Cardiovascular Diseases
Co-Principal Investigator
- 張皓智 Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- 季聖筑 Division of Ophthalmology
- Kang-Ling Wang 臨床試驗科
Co-Principal Investigator
Principal Investigator
Co-Principal Investigator
- 吳書豪 Division of Cardiovascular Diseases
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
135 participants
